Small,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 30, 2024
Novel
inorganic
sonosensitizers
with
excellent
reactive
oxygen
species
(ROS)
generation
activity
and
multifunctionality
are
appealing
in
sonodynamic
therapy
(SDT).
Herein,
amorphous
bismuth
(Bi)-doped
CoFe-layered
double
hydroxide
(a-CoBiFe-LDH)
nanosheets
proposed
via
crystalline-to-amorphous
phase
transformation
strategy
as
a
new
type
of
bifunctional
sonosensitizer,
which
allows
ultrasound
(US)
to
trigger
ROS
for
magnetic
resonance
imaging
(MRI)-guided
SDT.
Importantly,
a-CoBiFe-LDH
exhibit
much
higher
(≈6.9
times)
than
that
traditional
TiO
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
36(16)
Published: Feb. 1, 2024
Abstract
Intractable
infected
microenvironments
caused
by
drug‐resistant
bacteria
stalls
the
normal
course
of
wound
healing.
Sono‐piezodynamic
therapy
(SPT)
is
harnessed
to
combat
pathogenic
bacteria,
but
superabundant
reactive
oxygen
species
(ROS)
generated
during
SPT
inevitably
provoke
severe
inflammatory
response,
hindering
tissue
regeneration.
Consequently,
an
intelligent
nanocatalytic
membrane
composed
poly(lactic‐co‐glycolic
acid)
(PLGA)
and
black
phosphorus
/V
2
C
MXene
bio‐heterojunctions
(2D
‐bioHJs)
devised.
Under
ultrasonication,
2D
‐bioHJs
effectively
eliminate
disrupting
metabolism
electron
transport
chain
(ETC).
When
ultrasonication
ceases,
they
enable
elimination
SPT‐generated
ROS.
The
act
as
a
“lever”
that
achieves
balance
between
ROS
generation
annihilation,
delivering
both
antibacterial
anti‐inflammatory
properties
engineered
membrane.
More
importantly,
in
vivo
assays
corroborate
membranes
transform
stalled
chronic
environment
into
regenerative
one
eradicating
bacterial
population,
dampening
NF‐κB
pathway
promoting
angiogenesis.
As
envisaged,
this
work
demonstrates
novel
tactic
arm
with
programmed
effects
remedy
refractory
wounds
from
drug‐fast
bacteria.
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
36(23)
Published: Feb. 27, 2024
Abstract
Although
metal
single‐atom
(SA)‐based
nanomaterials
are
explored
as
sonosensitizers
for
sonodynamic
therapy
(SDT),
they
normally
exhibit
poor
activities
and
need
to
combine
with
other
therapeutic
strategies.
Herein,
the
deposition
of
SAs
on
oxygen
vacancy
(OV)‐rich
WO
3−
x
nanosheets
generate
a
synergistic
effect
efficient
SDT
is
reported.
Crystalline
3
OV‐rich
first
prepared
by
simple
calcination
·H
2
O
under
an
air
N
atmosphere,
respectively.
Pt,
Cu,
Fe,
Co,
Ni
then
deposited
obtain
SA‐decorated
nanocomposites
(M‐WO
).
Importantly,
Cu‐WO
sonosensitizer
exhibits
much
higher
activity
ultrasound
(US)‐induced
production
reactive
species
than
that
Cu
,
which
also
M‐WO
nanosheets.
Both
experimental
theoretical
results
suggest
excellent
performance
should
be
attributed
between
OVs.
Therefore,
after
polyethylene
glycol
modification,
can
quickly
kill
cancer
cells
in
vitro
effectively
eradicate
tumors
vivo
US
irradiation.
Transcriptome
sequencing
analysis
further
molecular
validation
‐mediated
SDT‐activated
apoptosis
TNF
signaling
pathways
potential
drivers
tumor
induction.
Chemical Reviews,
Journal Year:
2024,
Volume and Issue:
124(13), P. 8307 - 8472
Published: June 26, 2024
Due
to
the
intrinsic
non-invasive
nature,
cost-effectiveness,
high
safety,
and
real-time
capabilities,
besides
diagnostic
imaging,
ultrasound
as
a
typical
mechanical
wave
has
been
extensively
developed
physical
tool
for
versatile
biomedical
applications.
Especially,
prosperity
of
nanotechnology
nanomedicine
invigorates
landscape
ultrasound-based
medicine.
The
unprecedented
surge
in
research
enthusiasm
dedicated
efforts
have
led
mass
multifunctional
micro-/nanosystems
being
applied
biomedicine,
facilitating
precise
diagnosis,
effective
treatment,
personalized
theranostics.
deployment
applications
is
rooted
profound
understanding
relationship
among
composition,
structure,
property,
bioactivity,
application,
performance.
In
this
comprehensive
review,
we
elaborate
on
general
principles
regarding
design,
synthesis,
functionalization,
optimization
abundant
particular,
recent
advancements
imaging
are
meticulously
summarized.
Furthermore,
systematically
elucidate
state-of-the-art
studies
concerning
progress
therapeutic
targeting
various
pathological
abnormalities
including
cancer,
bacterial
infection,
brain
diseases,
cardiovascular
metabolic
diseases.
Finally,
conclude
provide
an
outlook
field
with
in-depth
discussion
challenges
faced
future
developments
further
extensive
clinical
translation
application.
Small,
Journal Year:
2024,
Volume and Issue:
20(25)
Published: Jan. 15, 2024
Abstract
Sonodynamic
therapy
(SDT)
as
a
promising
non‐invasive
anti‐tumor
means
features
the
preferable
penetration
depth,
which
nevertheless,
usually
can't
work
without
sonosensitizers.
Sonosensitizers
produce
reactive
oxygen
species
(ROS)
in
presence
of
ultrasound
to
directly
kill
tumor
cells,
and
concurrently
activate
immunity
especially
after
integration
with
microenvironment
(TME)‐engineered
nanobiotechnologies
combined
therapy.
Current
sonosensitizers
are
classified
into
organic
inorganic
ones,
current
most
reviews
only
cover
highlighted
their
applications.
However,
there
have
few
specific
that
focus
on
including
design
principles,
regulation,
etc.
In
this
review,
first
according
rationales
rather
than
composition,
action
underlying
chemistry
highlighted.
Afterward,
what
how
TME
is
regulated
based
sonosensitizers‐based
SDT
nanoplatform
an
emphasis
targets‐engineered
elucidated.
Additionally,
applications
non‐cancer
diseases
also
outlined.
Finally,
setbacks
challenges,
proposed
potential
solutions
future
directions
pointed
out.
This
review
provides
comprehensive
detailed
horizon
sonosensitizers,
will
arouse
more
attentions
SDT.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(16)
Published: Feb. 21, 2024
Abstract
Cancer
cells
typically
display
redox
imbalance
compared
with
normal
due
to
increased
metabolic
rate,
accumulated
mitochondrial
dysfunction,
elevated
cell
signaling,
and
accelerated
peroxisomal
activities.
This
may
regulate
gene
expression,
alter
protein
stability,
modulate
existing
cellular
programs,
resulting
in
inefficient
treatment
modalities.
Therapeutic
strategies
targeting
intra‐
or
extracellular
states
of
cancer
at
varying
state
progression
trigger
programmed
death
if
exceeded
a
certain
threshold,
enabling
therapeutic
selectivity
overcoming
resistance
radiotherapy
chemotherapy.
Nanotechnology
provides
new
opportunities
for
modulating
their
excellent
designability
high
reactivity.
Various
nanomaterials
are
widely
researched
enhance
highly
reactive
substances
(free
radicals)
production,
disrupt
the
endogenous
antioxidant
defense
systems,
both.
Here,
physiological
features
described
challenges
illustrated.
Then,
that
classified
elaborated
upon
based
on
ability
target
regulations.
Finally,
future
perspectives
this
field
proposed.
It
is
hoped
review
guidance
design
nanomaterials‐based
approaches
involving
therapy,
especially
cancers
resistant
chemotherapy,
etc.
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
36(26)
Published: March 29, 2024
Abstract
Sonodynamic
therapy
(SDT)
is
applied
to
bladder
cancer
(BC)
given
its
advantages
of
high
depth
tissue
penetration
and
nontoxicity
due
the
unique
anatomical
location
near
abdominal
surface.
However,
low
electron–hole
separation
efficiency
wide
bandgap
sonosensitizers
limit
effectiveness
SDT.
This
study
aims
develop
a
TiO
2
‐Ru‐PEG
Schottky
heterojunction
sonosensitizer
with
narrow
for
SDT
in
BC.
Density
functional
theory
(DFT)
calculations
experiments
collectively
demonstrate
that
reduced
characteristic
crystalline‐amorphous
interface
formed
by
deposition
ruthenium
(Ru)
within
shell
layer
.
Thanks
enhancement
oxygen
adsorption
efficient
pairs,
promotes
generation
reactive
species
(ROS)
under
ultrasound
(US)
irradiation,
resulting
cell
cycle
arrest
apoptosis
tumor
cells.
The
vivo
results
prove
boosted
subcutaneous
orthotopic
models
while
exhibiting
good
safety.
adopts
complex
optimizing
sonosensitizers,
contributing
progress
improvement
strategies
presenting
paradigm
BC
therapy.
ACS Nano,
Journal Year:
2024,
Volume and Issue:
18(2), P. 1516 - 1530
Published: Jan. 3, 2024
Biodegradable
silicate
nanoconstructs
have
aroused
tremendous
interest
in
cancer
therapeutics
due
to
their
variable
framework
composition
and
versatile
functions.
Nevertheless,
low
intratumoral
retention
still
limits
practical
application.
In
this
study,
oxygen
vacancy
(OV)-enriched
bimetallic
nanozymes
with
Fe–Ca
dual
active
sites
via
modification
of
oxidized
sodium
alginate
gallic
acid
(GA)
loading
(OFeCaSA-V@GA)
were
developed
for
targeted
aggregation-potentiated
therapy.
The
band
gap
silica
markedly
decreased
from
2.76
1.81
eV
by
codoping
Fe3+
Ca2+,
enabling
its
excitation
a
650
nm
laser
generate
reactive
species.
OV
that
occurred
the
hydrothermal
synthetic
stage
OFeCaSA-V@GA
can
anchor
metal
ions
form
an
atomic
phase,
offering
massive
fabrication
method
single-atom
nanozymes.
Density
functional
theory
results
reveal
Ca
promote
adsorption
H2O2,
Fe
accelerate
dissociation
thereby
realizing
synergetic
catalytic
effect.
More
importantly,
delivery
induce
morphological
transformation
at
tumor
sites,
leading
high
(the
highest
rate
is
36.3%)
theranostic
components
cells.
Thus,
finding
may
offer
ingenious
protocol
designing
engineering
highly
efficient
long-retention
nanodrugs.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
34(26)
Published: Feb. 27, 2024
Abstract
Reactive
oxygen
species
(ROS)‐induced
endoplasmic
reticulum
(ER)
stress
in
sonodynamic
therapy
(SDT)
can
elicit
immunogenic
cell
death
(ICD)‐initiated
antitumor
immunity
for
augmented
sono‐immunotherapy.
However,
unsatisfactory
activity
and
mediocre
ER
induction
ability
of
sonosensitizers
essentially
restrict
SDT
efficacy
ICD
stimulation.
Herein,
a
versatile
ER‐targeting
Iridium(III)
nanosonosensitizer
is
developed
as
superior
inducer
boosted
tumor
An
ingenious
cholic
acid
(CA)‐functionalized
sonosensitizer
Ir‐CA
well‐designed
skillfully
crosslinked
with
human
serum
albumin
(HSA)
to
form
HSA@Ir‐CA.
With
high
stability,
favorable
tumor‐targeting
ability,
reduction‐responsiveness,
HSA@Ir‐CA
preferentially
accumulates
sites
enhanced
cellular
uptake,
followed
by
rapid
disassembly
responding
intracellular
reductive
environment.
The
uncaged
selectively
accumulate
precisely
disrupt
situ
produced
type
I
II
ROS
upon
US
irradiation
high‐efficiency
SDT.
Moreover,
the
maximized
eminently
amplifies
evoke
robust
systemic
immunity,
inhibiting
growths
primary/distant
tumor,
lung
metastasis,
recurrence.
This
combined
immune
checkpoint
inhibitor
(αPD‐L1)
further
achieves
reinforced
therapeutic
outcome
against
immunologically
“cold”
tumor.
study
presents
an
effective
paradigm
optimize
amplify
ICD‐initiated
responses